Quick Answer
AETHLON MEDICAL INC reported Total Revenue of $0.00 for fiscal year 2024.
AETHLON MEDICAL INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | $0.00 -100.0% |
$574.2K +95.2% |
$294.2K -55.4% |
$659.1K +1.4% |
$650.2K +183.2% |
| Revenue (ASC 606) | — | $0.00 -100.0% |
$574.2K +95.2% |
$294.2K -55.4% |
$659.1K +1.4% |
$650.2K +183.2% |
| Net Income | -$13.39M -9.7% |
-$12.21M -1.5% |
-$12.03M -15.5% |
-$10.42M -32.1% |
-$7.89M -23.7% |
-$6.37M -2.9% |
| Diluted EPS | -$8.58 +77.9% |
-$38.87 -563.3% |
-$5.86 -725.4% |
-$0.71 | — | — |
| Total Assets | $7.36M -10.8% |
$8.25M -52.9% |
$17.51M -9.8% |
$19.42M +82.0% |
$10.67M +2.7% |
$10.39M +151.9% |
| Cash and Equivalents | $5.50M +1.1% |
$5.44M -62.6% |
$14.53M -14.9% |
$17.07M +73.1% |
$9.86M +2.7% |
$9.60M |
| Stockholders Equity | $5.12M -11.1% |
$5.77M -61.7% |
$15.06M -11.3% |
$16.99M +80.2% |
$9.43M +0.2% |
$9.41M +288.0% |
| Operating Income | -$9.34M +26.1% |
-$12.64M -6.2% |
-$11.90M -14.2% |
-$10.42M -32.1% |
-$7.89M -33.1% |
-$5.93M +1.2% |
| Shares Outstanding | 2.01M +511.7% |
328,728 -85.7% |
2.30M -85.1% |
15.42M +26.9% |
12.15M +29.7% |
9.37M +639.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2022 | $0.00 | -100.0% | — |
| Revenue (ASC 606) | December 31, 2022 | $0.00 | -100.0% | — |
| Net Income | December 31, 2025 | -$2.02M | -15.0% | -35.7% |
| Diluted EPS | December 31, 2025 | -$2.45 | +75.6% | +34.5% |
| Total Assets | December 31, 2025 | $8.06M | +23.5% | +10.0% |
| Cash and Equivalents | December 31, 2025 | $6.96M | +44.2% | +18.8% |
| Stockholders Equity | December 31, 2025 | $6.71M | +54.9% | +16.8% |
| Operating Income | December 31, 2025 | -$2.06M | -13.6% | -36.6% |
| Shares Outstanding | December 31, 2025 | 973,213 | -93.0% | +27.8% |
- AETHLON MEDICAL INC reported Total Revenue of $0.00 for fiscal year 2024.
- AETHLON MEDICAL INC showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- AETHLON MEDICAL INC reported Revenue (ASC 606) of $0.00 for fiscal year 2024.
- AETHLON MEDICAL INC showed a decrease of -100.0% in Revenue (ASC 606) compared to the prior fiscal year.
- AETHLON MEDICAL INC reported Net Income of -$13.39 million for fiscal year 2025.
- AETHLON MEDICAL INC showed a decrease of -9.7% in Net Income compared to the prior fiscal year.
- AETHLON MEDICAL INC reported Diluted EPS of $8.58 per share (loss) for fiscal year 2025.
- AETHLON MEDICAL INC showed an increase of +77.9% in Diluted EPS compared to the prior fiscal year.
- AETHLON MEDICAL INC reported Total Assets of $7.36 million for fiscal year 2025.
- AETHLON MEDICAL INC showed a decrease of -10.8% in Total Assets compared to the prior fiscal year.
- AETHLON MEDICAL INC reported Cash and Equivalents of $5.50 million for fiscal year 2025.
- AETHLON MEDICAL INC showed an increase of +1.1% in Cash and Equivalents compared to the prior fiscal year.
- AETHLON MEDICAL INC reported Stockholders Equity of $5.12 million for fiscal year 2025.
- AETHLON MEDICAL INC showed a decrease of -11.1% in Stockholders Equity compared to the prior fiscal year.
- AETHLON MEDICAL INC reported Operating Income of -$9.34 million for fiscal year 2025.
- AETHLON MEDICAL INC showed an increase of +26.1% in Operating Income compared to the prior fiscal year.
- AETHLON MEDICAL INC reported Shares Outstanding of 2.01 million shares for fiscal year 2025.
- AETHLON MEDICAL INC showed an increase of +511.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: